之江生物(688317.SH)： 7個相關檢測產品獲得歐盟CE認證
格隆匯7月19日丨之江生物(688317.SH)公佈，公司及全資子公司於近期獲得七項相關認證。
產品名稱分別為“Novel Coronavirus (2019-nCoV) IgM/IgG Antibody Detection Kit (Colloidal Gold)新型冠狀病毒(2019-nCoV)抗體檢測試劑盒(膠體金法)”、“Liferiver SARS-CoV-2 L452R & E484K/Q Mutations Detection Kit新型冠狀病毒(SARS-CoV-2)L452R 和 E484K/Q 突變檢測試劑盒”、“Novel Coronavirus (2019-nCoV) Real Time Multiplex RT-PCR Kit (Detection for 3 Genes)新型冠狀病毒2019-nCoV核酸檢測試劑盒(熒光 PCR 法)”、“Viral RNA Extraction Kit核酸提取試劑”、“Automated Workstation for Nucleic Acid Extraction and PCR Test全自動核酸提取及檢測分析系統”、“Automated Workstation for Nucleic Acid Extraction & PCR Setup (model: Autra9600 Plus)全自動核酸工作站”、“Automated Nucleic Acid Extraction Instrument (EX9600)全自動核酸提取儀”；使用範圍均為歐盟國家和認可歐盟 CE認證的國家。
公司表示，公司以上產品獲得歐盟CE認證後，可在歐盟國家和認可歐盟CE認證的國家進行銷售，進一步提升了公司的國際化競爭力，對於公司擴充海外銷售產品品類及國際業務拓展具有積極作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
